The company has struggled to supply the drug to patients due to overwhelming popularity.
Novo Nordisk Increases Supply of Lower-Dose Wegovy to Meet Continued Demand
You May Also Like
Global Launch Strategies in the Current Political Climate
February 19, 2025
FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk
February 19, 2025
Navigating Distrust: Pharma in the Age of Social Media
February 18, 2025
+ There are no comments
Add yours